Dr Reddy’s Laboratories has launched Amlodipine Besylate and Benazepril Hydrochloride capsules (5 mg/40 mg and 10 mg/40 mg), a bioequivalent generic version of LOTREL capsules in the US market on July 05, 2011, following the approval by the United States Food & Drug Administration (USFDA) of Dr Reddy’s Abbreviated New Drug Application (ANDA) for the said capsules.
The LOTREL brand has U.S sales of approximately $290 million for the most recent twelve months ending March 2011 according to IMS Health. Dr Reddy’s Amlodipine Besylate and Benazepril Hydrochloride capsules are available in 100 count bottles.
Recently, Dr Reddy’s Laboratories had launched Levofloxacin tablets 250mg, 500mg, and 750mg, a bioequivalent generic version of Levaquin tablets in the US market on June 20, 2011, following the approval by the USFDA of the company’s ANDA for Levofloxacin tablets.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1867.80 |
| Dr. Reddys Labs. | 1301.30 |
| Cipla | 1433.10 |
| Zydus Lifesciences | 1112.10 |
| Lupin | 2356.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: